Markets:

Overview

News

Currencies

International

Treasuries

Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

7.720 +0.540 (+7.52%)

Streaming Delayed Price Updated: 12:01 PM EST, Feb 11, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Aligos Therapeutics, Inc. - Common stock

< Previous 1 2 3 4 Next >

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 27, 2025

Via Benzinga

Earnings Scheduled For August 6, 2025 ↗

August 06, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 12, 2025

Via Benzinga

Earnings Scheduled For May 6, 2025 ↗

May 06, 2025

Via Benzinga

Aligos Therapeutics's Earnings Outlook ↗

May 05, 2025

Via Benzinga

Monday's session: top gainers and losers ↗

March 10, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.

Via Chartmill

How Is The Market Feeling About Aligos Therapeutics? ↗

January 14, 2025

Via Benzinga

Recap: Aligos Therapeutics Q4 Earnings ↗

March 12, 2024

Via Benzinga

Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗

March 10, 2025

Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir...

Via Benzinga

Topics Economy Stocks

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

March 10, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Top movers in Monday's pre-market session ↗

March 10, 2025

The US market is yet to commence its session on Monday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.

Via Chartmill

Aligos Therapeutics Earnings Preview ↗

March 11, 2024

Via Benzinga

Earnings Outlook For Aligos Therapeutics ↗

November 01, 2023

Via Benzinga

Earnings Scheduled For March 10, 2025 ↗

March 10, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 13, 2025

Via Benzinga

Week In Review: Nanjing Triastek Partners With BioNTech In A $1.2 Billion Drug Development Deal ↗

July 27, 2024

Triastek will develop oral RNA therapeutics with Germany’s BioNTech based on its 3D printing technology. Triastek will receive a $10 million upfront payment and up to $1.2 billion in milestones, plus...

Via Talk Markets

ALGS Stock Earnings: Aligos Therapeutics Misses EPS for Q1 2024 ↗

May 07, 2024

ALGS stock results show that Aligos Therapeutics missed analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

March 15, 2024

Via Benzinga

Earnings Scheduled For March 12, 2024 ↗

March 12, 2024

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Via Benzinga

Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗

December 08, 2023

Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 07, 2023

Via Benzinga

Why Is Tharimmune (THAR) Stock Down 8% Today? ↗

November 20, 2023

Tharimmune stock is falling after the company announced a reverse stock split for THAR shares that goes into effect later today.

Via InvestorPlace

Why Is Aligos Therapeutics (ALGS) Stock Down 5% Today? ↗

November 20, 2023

Aligos Therapeutics stock is falling alongside news of a secondary offering for ALGS that it won't see any proceeds of the sales from.

Via InvestorPlace

Why Applied UV Shares Are Trading Higher By Around 96%; Here Are 20 Stocks Moving Premarket ↗

November 20, 2023

Shares of Applied UV, Inc. (NASDAQ: AUVI) shares jumped in pre-market trading after the company reported third-quarter results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

November 20, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

November 20, 2023

It's time to start the week with a breakdown of the biggest pre-market stock movers traders need to watch on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 27, 2023

Via Benzinga

Why Aligos Therapeutics (ALGS) Stock Is Nosediving ↗

October 23, 2023

Aligos Therapeutics Inc (NASDAQ: ALGS) shares are trading lower by 15.8% to $0.64 Monday afternoon after the company announced $92 million in private placement financing

Via Benzinga

Week In Review: LaNova Sells Pre-Clinical ADC To AstraZeneca In $600 Million Deal ↗

May 20, 2023

LaNova Medicines has sold global rights for a pre-clinical antibody drug conjugate candidate to AstraZeneca for $600 million, including $55 million upfront plus royalties on sales. Meanwhile, Amoytop...

Via Talk Markets

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Aligos Therapeutics, Inc. - Common stock (NQ:ALGS)

Headline News about Aligos Therapeutics, Inc. - Common stock

Starting at $3.75/week.

Subscribe Today